NIAID Goes Dark on Infectious Disease Trial Funding
Published Date: 4/3/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed video meeting on May 1, 2025, to review important grant applications for clinical trials. This meeting affects researchers seeking funding and keeps sensitive info private. It helps decide who gets money to fight infectious diseases and supports exciting new medical research.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed review decides clinical trial funding
If you are a researcher applying for the NIAID Clinical Trial Implementation Cooperative Agreement (U01, clinical trial required), a closed video meeting on May 1, 2025, from 11:00 a.m. to 1:00 p.m. will review and evaluate grant applications. That meeting helps decide who receives funding for infectious disease clinical trials.
Confidential handling of grant application details
The meeting will be closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information in grant applications. This keeps sensitive technical ideas and personal data private during the May 1, 2025 review.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13802 — Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2
The National Institutes of Health is offering special mouse strains that help study a rare heart rhythm disorder called CPVT. These mice let scientists explore how a key heart gene works and test new gene therapies. Researchers interested in this tool can access it now—no patents, just pure science ready to speed up discoveries!
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
Previous / Next Documents
Previous: 2025-05726 — Noise Compatibility Program for Laredo International Airport, Webb County, Texas
The City of Laredo has submitted a plan to reduce noise around Laredo International Airport, and the FAA is now reviewing it. This plan affects people living near the airport by aiming to make their neighborhoods quieter. The public can check out the plan and share their thoughts before a final decision is made within 180 days, with no immediate costs announced.
Next: 2025-05728 — National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 28, 2025, to review special grant applications focused on training in data science for infectious and immune diseases. This meeting affects researchers applying for these grants and helps decide who gets funding to boost important scientific training. The meeting is private to protect sensitive information and will be held via video.